scispace - formally typeset
W

Wenrong Zhou

Researcher at Shanghai Jiao Tong University

Publications -  5
Citations -  232

Wenrong Zhou is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Apical ectodermal ridge & Gene. The author has an hindex of 4, co-authored 4 publications receiving 197 citations.

Papers
More filters
Journal ArticleDOI

MiR-140 is co-expressed with Wwp2-C transcript and activated by Sox9 to target Sp1 in maintaining the chondrocyte proliferation

TL;DR: It is detected that miR‐140 was uniquely expressed in chondrocyte and suppressed by Wnt/β‐catenin signalling, and Sp1, the activator of the cell cycle regulator p15INK4b, was identified as a target of miR•140 in maintaining the chondrogenic proliferation.
Journal ArticleDOI

Foxp1/2/4 regulate endochondral ossification as a suppresser complex.

TL;DR: Foxp1/2/4 proteins are established as coordinators of osteogenesis and chondrocyte hypertrophy in developing long bones and it is suggested that a novel transcriptional repressor network involving Foxp1-2-4 may regulate Runx2 during endochondral ossification.
Journal ArticleDOI

Ndrg2 regulates vertebral specification in differentiating somites.

TL;DR: It is demonstrated that Ndrg2, a tumor suppressor gene, was dynamically expressed in the presomitic mesoderm (PSM) and at early stage of differentiating somites and revealed that NDRg2 modulates vertebral identity in segmented somites rather than in the PSM.
Journal ArticleDOI

Misexpression of Pknox2 in Mouse Limb Bud Mesenchyme Perturbs Zeugopod Development and Deltoid Crest Formation

TL;DR: Results indicated that PKnox2 misexpression affected mesenchymal condensation and early chondrogenic differentiation in the zeugopod skeletons of transgenic embryos, suggesting Pknox2 as a potential regulator of zeugobod and deltoid crest formation.
Proceedings ArticleDOI

1425 In vivo CRISPR screens identify HDAC1 as an immune sensitizer reversing immune resistance driven by STK11 loss

TL;DR: In this article , a two-step approach was taken to uncover tumor suppressor gene loss driving immune evasion as step one, and immune sensitizers specifically reversing the immune evasion driven by certain tumor suppressionor loss as step two.